Oncologica UK Logo

Oncologica UK

Oncologica | Leading precision Cancer genetic and Allergy testing lab

Who is Oncologica UK?

Oncologica® is a leading precision oncology and genomics laboratory providing clinical testing and contract research services. Oncologica is based at the prestigious Chesterford Research Park, Cambridge, UK. Oncologica® provides precision oncology testing to address demand for personalised cancer medicine. Oncologica also provides COVID-19 testing services and viral sequencing to track new SARS COVID-19 variants. Oncologica® was founded in 2014 with a mission to harness molecular sequencing technologies to deliver an increased range of personalised medicine opportunities to patients with cancer. Oncologica® was one of the first clinically approved laboratories in Europe to harness the power of genomic profiling to deliver personalised cancer medicine. Oncologica® is at the forefront of providing precision oncology services that help ensure patients derive maximum benefit from a new generation of personalised drugs. Oncologica® also functions as a Contract Research Organisation (CRO) to support biomarker and drug development programmes.

This company is:

Educational institution

Cambridge, United Kingdom

51-100 Employees

Founding year: 2014



Products & services of Oncologica UK

Product Contact Us | Oncologica | Telephone and Email Support | Live Chat image
Service

Verified

Contact Us | Oncologica | Telephone and Email Support | Live Chat

Whether you have a question about our services or a query about a test you have ordered, please contact us

Product Oncologica®’s Coronafocus COVID-19 Test and Sequence platform enables rapid identification of variants of concern | Oncologica image
Product

Verified

Oncologica®’s Coronafocus COVID-19 Test and Sequence platform enables rapid identification of variants of concern | Oncologica

Oncologica®’s Coronafocus COVID-19 Test and Sequence platform enables rapid identification of variants of concern | Dr David Fenelly | Prof Umberto Tirelli | Prof Daniele Generali | Karan Jensen was diagnosed in 2017, aged 48 with cervical cancer. Karan ordered the Oncofocus® Test to identify additional treatment options and shares her story here in the following Q&A. | Prof Giovanni Palazzoni | For Patients | For Clinicians | How did your diagnosis come about? | What happened after you were diagnosed? | Did this treatment work? | Did the second round of treatment work? | Did you experience any side effects of chemotherapy? | How did you feel when they told you that you cancer was incurable? | What did you find searching online? | Was it easy getting the Oncofocus® test done? | What were the results of the Oncofocus® test? | What happened when you knew the results of the test? | Was this new treatment successful? | Are you still receiving treatment? | What are your thoughts on the Oncofocus® test? | What is happening now?

View all products


Keywords

Precision Oncology
Molecular Pathology
Cancer Treatments
Tumour Profiling
Targeted Therapies
Next Generation Sequencing NGS
DNA & RNA Analysis
Immunotherapy
Molecular tissue analytics
Research and Development
Drug Discovery
Covid-19 PCR testing
Coronavirus variant sequencing
Cancer DNA profiling
Covid-19 variant identification
Travel PCR test kits
Genomic cancer diagnostics
Polymerase Chain Reaction tests
Covid-19 variant detection
Genomic sequencing strategies
Hospital & Health Care

Industries

Healthcare

Use Cases of Oncologica UK

text-slider-1

Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates | Oncologica

Br J Cancer. 2004 Aug 16;91(4):714-9. Williams GH, Swinn R, Prevost AT, De Clive-Lowe P, Halsall I, Going JJ, Hales CN, Stoeber K, Middleton SJ.


Contact of Oncologica UK

City: Cambridge

State: England

Country: United Kingdom



Frequently asked questions (FAQ) about Oncologica UK

The company Oncologica UK is located in Cambridge, England, United Kingdom. It's worth noting that the company may has more corporate locations

As of the latest available information Oncologica UK has around 51-100 employees worldwide.

Oncologica UK was founded in 2014

The company Oncologica UK has it's main focus in the industries of Healthcare

Based on the founding year and the amount of employees the company Oncologica UK seems to be a Medium-Sized Company at the current state. Note that over time that status can change

Competitors of Oncologica UK

OmniSeq Logo

OmniSeq

United States

51-100 Employees

2015

View

Pangaea Oncology Logo

Pangaea Oncology

Spain

View

Oncacare Logo

Oncacare

United Kingdom

51-100 Employees

2020

View

ONCOtherapeutics Logo

ONCOtherapeutics

United States

11-50 Employees

2007

View

OncoBay Clinical Logo

OncoBay Clinical

United States

11-50 Employees

View

OncoCDx | Artificial Intelligence for Personalized Medicine Logo

OncoCDx | Artificial Intelligence for Personalized Medicine

United Kingdom

11-50 Employees

2018

View

Oncocare Health Incorporated Logo

Oncocare Health Incorporated

Canada

1-10 Employees

2015

View

GenomOncology Logo

GenomOncology

United States

11-50 Employees

2012

View


Suitable topics for Oncologica UK

Topics which have been searched by others and may be interesting for you: